These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16139390)

  • 1. The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments.
    Ogungbenro K; Graham G; Gueorguieva I; Aarons L
    Comput Methods Programs Biomed; 2005 Nov; 80(2):115-25. PubMed ID: 16139390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0.
    Bazzoli C; Retout S; Mentré F
    Comput Methods Programs Biomed; 2010 Apr; 98(1):55-65. PubMed ID: 19892427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.
    Retout S; Mentré F; Bruno R
    Stat Med; 2002 Sep; 21(18):2623-39. PubMed ID: 12228881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of simulated annealing for finding optimal population designs.
    Duffull SB; Retout S; Mentré F
    Comput Methods Programs Biomed; 2002 Jul; 69(1):25-35. PubMed ID: 12088590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
    Bazzoli C; Retout S; Mentré F
    Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates.
    Retout S; Comets E; Samson A; Mentré F
    Stat Med; 2007 Dec; 26(28):5162-79. PubMed ID: 17486667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of individual and population designs using Splus.
    Retout S; Mentré F
    J Pharmacokinet Pharmacodyn; 2003 Dec; 30(6):417-43. PubMed ID: 15000423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trial.
    Chenel M; Ogungbenro K; Duval V; Laveille C; Jochemsen R; Aarons L
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):737-56. PubMed ID: 16341474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a simulated annealing algorithm to fit compartmental models with an application to fractal pharmacokinetics.
    Marsh RE; Riauka TA; McQuarrie SA
    J Pharm Pharm Sci; 2007; 10(2):168-79. PubMed ID: 17706176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.
    Dumont C; Lestini G; Le Nagard H; Mentré F; Comets E; Nguyen TT;
    Comput Methods Programs Biomed; 2018 Mar; 156():217-229. PubMed ID: 29428073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An implementation of the Expectation-Maximisation (EM) algorithm for population pharmacokinetic-pharmacodynamic modelling in ACSLXTREME.
    Yates JW
    Comput Methods Programs Biomed; 2009 Oct; 96(1):49-62. PubMed ID: 19410328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteria.
    Tod M; Rocchisani JM
    Comput Methods Programs Biomed; 1996 Jun; 50(1):13-22. PubMed ID: 8835836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of population pharmacokinetic experiments using prior information.
    Ogungbenro K; Aarons L
    Xenobiotica; 2007; 37(10-11):1311-30. PubMed ID: 17968747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fast algorithm for computing inbreeding coefficients in large populations.
    Sargolzaei M; Iwaisaki H; Colleau JJ
    J Anim Breed Genet; 2005 Oct; 122(5):325-31. PubMed ID: 16191041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sampling schedule design towards optimal drug monitoring for individualizing therapy.
    Ji S; Zeng Y; Wu P; Lee EJ
    Comput Methods Programs Biomed; 2005 Oct; 80(1):57-63. PubMed ID: 16040154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal design for multivariate response pharmacokinetic models.
    Gueorguieva I; Aarons L; Ogungbenro K; Jorga KM; Rodgers T; Rowland M
    J Pharmacokinet Pharmacodyn; 2006 Apr; 33(2):97-124. PubMed ID: 16550455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSO-based multiobjective optimization with dynamic population size and adaptive local archives.
    Leong WF; Yen GG
    IEEE Trans Syst Man Cybern B Cybern; 2008 Oct; 38(5):1270-93. PubMed ID: 18784011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POPED, a software for optimal experiment design in population kinetics.
    Foracchia M; Hooker A; Vicini P; Ruggeri A
    Comput Methods Programs Biomed; 2004 Apr; 74(1):29-46. PubMed ID: 14992824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experiments.
    Graham G; Aarons L
    Stat Med; 2006 Dec; 25(23):4004-19. PubMed ID: 16463254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive reconstruction of pipe-shaped human organs from 3D ultrasonic volume.
    Min K; Choi YJ
    Comput Med Imaging Graph; 2006 Mar; 30(2):109-21. PubMed ID: 16487680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.